How a Dutch AI Startup Is Quietly Transforming Hearing Care

Jan de Vries · 2026-08-28

You know, sometimes the most interesting startup news isn't the massive $100 million rounds. It's the smaller, smarter funding that signals a real shift in how an entire industry might operate. That's what caught my eye with Clementine, a startup out of Maastricht in the Netherlands. They just secured $2 million in Seed funding, and their focus is something we don't talk about enough: hearing care. It's a massive, often silent problem. But this team isn't just building another app. They're using AI to tackle the huge gap between needing help and actually getting it. Let's break down why this deal matters. ### The Backing of a Specialist Investor The $2 million round was led by Healthy.Capital, an Amsterdam-based early-stage investor that really knows its stuff in HealthTech. They've backed companies like Pharmi and OpenUp, so they have a sharp eye for what works. Their managing partner, Douwe Jippes, put it perfectly: "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally." He believes their approach will fundamentally change how people with hearing disabilities engage with healthcare. That's the kind of impact-focused backing every startup dreams of—investors who get the mission, not just the numbers. ### Meet Matthew: The AI Agent Changing the Conversation So, what exactly did they build? The core of Clementine's platform is an AI hearing care agent named Matthew. Think of Matthew as a compassionate, available-anytime guide. Founded in 2024 by CEO Vince van de Weijer, Clementine describes itself as the world's first AI hearing activation platform built for this specific industry. Here's what makes Matthew different: - It answers questions 24/7, with no judgment and no waiting list. - It educates users and helps them overcome both emotional and practical barriers to care. - It gently guides people toward the appropriate next steps, long before they ever set foot in a clinic. For clinics drowning in calls and admin, this is a game-changer. Matthew handles the initial conversations, turning inquiries into actual bookings. For patients, it means clearer communication and, ultimately, better hearing outcomes. As van de Weijer says, "Clinics don't need more leads; they need better conversations at the right moment." ### The Scale of the Problem and the Opportunity Let's talk about why this is so urgent. The numbers are staggering. Hearing loss affects an estimated 1.5 billion people worldwide. Now, get this—nearly 80% of those people never seek treatment. And for those who finally do? They typically wait over eight years from first noticing a problem. Eight years. That's a massive failure of our current systems. Clementine's bet is that by pairing AI with behavioral science, they can create a judgment-free, always-on starting point. It's about meeting people where they are, in those early moments of doubt or curiosity, and making the first step effortless. ### What's Next for Clementine? This Seed funding isn't happening in a vacuum. It comes right after Clementine expanded into North America through a partnership with Zoolstra, a marketing agency for hearing clinics in the United States and Canada. That's a smart, fast move. The new capital has a clear purpose: - Deepening the company's core AI capabilities to make Matthew even more helpful. - Expanding partnerships beyond hearing clinics to include optical retailers and other healthcare organizations, creating more touchpoints for people who need help. It's a classic case of a startup finding a painful, overlooked friction point in a giant market and applying a smart, scalable tech solution. They're not just selling software to clinics; they're trying to rebuild the front door to hearing care for millions. And with $2 million and the right partners, they're now powered up to try.